KPS-0373, Low dose
Sponsors
Kissei Pharmaceutical Co., Ltd.
Conditions
Spinocerebellar Degeneration
Phase 3
An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
CompletedNCT01970111
Updated: 2016-04-18
A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
CompletedNCT01970098
Start: 2013-10-09End: 2015-01-31Updated: 2018-12-14
A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
CompletedNCT01970124
Updated: 2016-04-18
A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
CompletedNCT01970137
Updated: 2016-04-18